Bone Densitometer Market Size Worth USD 434.7 Million in 2030 - Exclusive Report by Emergen Research

The global bone densitometer market size is expected to reach USD 434.7 Million at a steady revenue CAGR of 4.7% in 2030, according to latest analysis by Emergen Research The bone densitometer market is expected to witness significant growth in the coming years. A bone densitometer is a medical device used to measure bone density and diagnose osteoporosis, a disease that weakens bones and makes them more susceptible to fractures. The increasing prevalence of osteoporosis and bone-related disorders is a major factor driving the growth of the market.

One of the key drivers of the bone densitometer market is the rising elderly population. According to the World Health Organization (WHO), the global population of people aged 65 and above is expected to reach 2.1 billion by 2050, up from 703 million in 2019. The aging population is more prone to bone fractures and other bone-related diseases, which is fueling the demand for bone densitometers.

Moreover, the increasing awareness about the benefits of early diagnosis and treatment of osteoporosis is also driving the market growth. Governments and healthcare organizations are promoting regular bone density testing, which is further boosting the demand for bone densitometers.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1461

However, there are certain restraints that could limit the growth of the bone densitometer market. The high cost of bone densitometers is one of the major challenges faced by the market. Moreover, the lack of skilled professionals to operate the device is another restraining factor. The installation and maintenance of the device also require specialized expertise, which further increases the cost of ownership.

Despite these challenges, the bone densitometer market is expected to grow significantly in the coming years. The market is driven by various growth factors such as technological advancements in the devices, increasing research and development activities, and rising healthcare expenditure.

Major Companies and Competitive Landscape:

The bone densitometer market is highly competitive with a number of players vying for market share. Some major companies in the global market report include General Electric Company, OSI Systems, Inc., DMS GROUP, BeamMed Ltd., Echolight S.p.a, Scanflex Healthcare AB, Medonica Co., LTD., Eurotec Medical Systems s.r.l., Hologic, Inc., and Swissray.

GE Healthcare, for instance, has developed the Lunar iDXA bone densitometer, which offers advanced features such as Vertebral Fracture Assessment (VFA) and Total Body Composition analysis. Hologic Inc. has also introduced a range of advanced bone densitometers, such as the Horizon DXA System and the Discovery DXA System, which offer high precision and accuracy in bone density measurements.

In addition to product innovation, companies in the bone densitometer market are also adopting various growth strategies such as mergers and acquisitions, partnerships, and collaborations to expand their market presence. For instance, in 2018, Hologic Inc. acquired Faxitron Bioptics, LLC, a leader in digital pathology and specimen radiography, to expand its offerings in the medical imaging and diagnostics market.

Moreover, companies are also focusing on expanding their distribution networks to reach a wider customer base. For example, in 2021, Swissray International partnered with Konsultronix, a leading provider of medical imaging solutions in Canada, to expand its distribution network in the country.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1461

Segmentation Insights for Bone Densitometer Market Report:

The global bone densitometer market has been segmented by Emergen Research based on technology, application, end-use, and region. In terms of technology, the market has been segmented into axial bone densitometry and peripheral bone densitometry. The axial bone densitometry segment includes dual-energy X-ray absorptiometry (DEXA) and quantitative computed tomography (QCT), while the peripheral bone densitometry segment includes technologies such as quantitative ultrasound (QUS), radiographic absorptiometry (RA), and other peripheral bone densitometry technologies.

Based on application, the market has been segmented into osteoporosis and osteopenia diagnosis, cystic fibrosis diagnosis, chronic kidney disease diagnosis, body composition measurement, and rheumatoid arthritis diagnosis. The end-use segment of the bone densitometer market includes hospitals and specialty clinics, diagnostic and imaging centers, and others.

Finally, the market has been analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America includes the United States, Canada, and Mexico, while Europe encompasses Germany, the United Kingdom, France, Italy, Spain, Sweden, BENELUX, and the rest of Europe. Asia Pacific comprises China, India, Japan, South Korea, and the rest of APAC. The Latin America segment includes Brazil and the rest of LATAM, while the Middle East and Africa region includes Saudi Arabia, the United Arab Emirates, South Africa, Israel, and the rest of the Middle East and Africa.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/bone-densitometer-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.